14 pharma companies post Q3 profits over $1B

In the U.S., patients spend more on hospital care and clinical services than they do on prescription drugs, yet pharmaceutical companies often pocket more of the money than in other parts of the industry, including most insurers and health systems. The third quarter of 2018 reveals this trend, with 14 drugmakers posting a profit above $1 billion.

In contrast to pharmaceutical companies, Nashville, Tenn.-based HCA Healthcare, one of the five major for-profit hospital systems that had the largest profit in the third quarter of 2018, reported a profit of $759 million. And Anthem, one of the largest insurers, saw a profit of $960 million in the third quarter.

Here are the 14 pharma companies that posted at least a $1 billion profit:

1. Pfizer ($4.1 billion)

2. Johnson & Johnson ($3.9 billion)

3. AbbVie ($2.75 billion)

4. Sanofi ($2.59 billion)

5. Gilead ($2.1 billion)

6. Merck ($1.95 billion)

7. Bristol Myers-Squibb ($1.9 billion)

8. Amgen ($1.86 billion)

9. GlaxoSmithKline ($1.84 billion)

10. Novartis ($1.62 billion)

11. Biogen ($1.44 billion)

12. Novo Nordisk ($1.38 billion)

13. Eli Lilly ($1.15 billion)

14. Celgene ($1.08 billion)

More articles on pharmacy:
CVS Health posts $1.4B profit, expects Aetna deal to close by Thanksgiving
Takeda inches closer to $62B takeover of Shire
Massachusetts drugmaker will cut 60% of workforce after failed drug trial


© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Content

Featured Webinars

Featured Whitepapers